Your browser is not able to display this multimedia content.
Problems viewing videos? youtube.com
Swiss pharmaceutical giant Roche has agreed to pay $46.8 billion to buy the 44 percent of California-based biotech pioneer Genentech that it doesn't already own. The AP's Mark Hamrick reports. (March 12)